| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |